A research team from Duke University has released a report that says unrelated umbilical cord blood transplants for myelodysplastic syndrome in children result in a three-year event-free survival of 61%. The details of this study appeared in the August 2009 issue of Biology of Blood and Marrow Transplantation. The source of stems cells is usually [...]

A story about a young girl with cerebral palsy in Colorado, who was treated with stem cell from her own cord blood, has been making headlines lately – with good reason. The treatments were successful. Dr. Joanne Kurtzberg, a professor of pediatrics and pathology at Duke University, was conducting a study where children with cerebral [...]

In Kolkata, a top official said that one of the leading stem cell banking groups in the Asia Pacific region, CordLife, is targeting an expansion of its business into China and India. “We’re looking at India and China as two big markets in terms of our stem cell business in the Asia Pacific region – keeping [...]

New information from a research study conducted at the Masonic Cancer Center at the University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood have significantly reduced risk of the disease returning. “We believe our finding provides evidence that using two units of UCB for [...]

Umbilical cord blood could provide the raw material needed to repair the hearts of thousands of babies born defective heart valves, according to cardiologists at the University Hospital of Munich. Those scientists say they are 5 to 7 years away from transplanting new heart valves into children with heart defects, made from the baby’s own [...]

Vision loss often occurs when corneal epithelial cells are lost or do not regenerate fast enough. In data presented at the annual meeting of the International Society for Stem Cell Research, Dr. David Harris demonstrated that cord blood stem cells can differentiate into these cells and form a cell sheet that is indistinguishable from corneal [...]

The National Comprehensive Cancer Network recently finished important updates to its Clinical Practice Guidelines in Oncology for acute myeloid leukemia and for non-Hodgkin’s lymphoma. The guidelines now note that acute myeloid leukemia should be treated based on regimens that have been established in clinical trials, and they emphasize the importance of using the regimens consistently [...]